Trial intelligence / Profile preview

Technosphere Insulin vs Insulin Lispro in T2DM

NCT00570687Phase 2Completed

Sponsor
MannKind
Start
Sep 2007
Primary completion
Jan 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of TI-Inhalation Powder B in type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Sep 2007; status: completed.

02

Drugs

TI-Inhalation Powder B
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00570687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00570687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call